Evidence map›Paper›PMID 38531868›Full record

ArticleNature communications2024

The level of protein in the maternal murine diet modulates the facial appearance of the offspring via mTORC1 signaling.

Meng Xie, Markéta Kaiser, Yaakov Gershtein, Daniela Schnyder, Ruslan Deviatiiarov, Guzel Gazizova, Elena Shagimardanova, Tomáš Zikmund, Greet Kerckhofs, Evgeny Ivashkin and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 7 countries.

Meng XieDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-6388-9789
Markéta KaiserCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.ORCID 0000-0002-5200-7365
Yaakov GershteinDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Daniela SchnyderDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9594-3823
Ruslan DeviatiiarovRegulatory Genomics Research Center, Kazan Federal University, Kazan, Russia.ORCID 0000-0003-0019-2076
Guzel GazizovaRegulatory Genomics Research Center, Kazan Federal University, Kazan, Russia.
Elena ShagimardanovaRegulatory Genomics Research Center, Kazan Federal University, Kazan, Russia.
Tomáš ZikmundCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.ORCID 0000-0003-2948-5198
Greet KerckhofsBiomechanics Lab, Institute of Mechanics, Materials, and Civil Engineering (iMMC), UCLouvain, Louvain-la-Neuve, Belgium.
Evgeny IvashkinA.N. Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Moscow, Russia.
Dominyka BatkovskyteDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0492-1259
Phillip T NewtonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2142-1798
Olov AnderssonDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6715-781X
Kaj FriedDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9997-7078
Oleg GusevRegulatory Genomics Research Center, Kazan Federal University, Kazan, Russia.
Hugo ZebergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-7118-1249
Jozef KaiserCentral European Institute of Technology, Brno University of Technology, Brno, Czech Republic.ORCID 0000-0002-7397-125X
Igor AdameykoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. igor.adameyko@meduniwien.ac.at.ORCID 0000-0001-5471-0356
Andrei S ChaginDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. andrei.chagin@gu.se.
Karolinska Institutet · SEKazan Federal University · RUCentral European Institute of Technology · CZKoltzov Institute of Developmental Biology · RUMedical University of Vienna · ATPeking University · CNUCLouvain · BE

Funding

Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0070314Vetenskapsrådet (Swedish Research Council) 2020-02298
6 · The paper itself

Abstract

The development of craniofacial skeletal structures is fascinatingly complex and elucidation of the underlying mechanisms will not only provide novel scientific insights, but also help develop more effective clinical approaches to the treatment and/or prevention of the numerous congenital craniofacial malformations. To this end, we performed a genome-wide analysis of RNA transcription from non-coding regulatory elements by CAGE-sequencing of the facial mesenchyme of human embryos and cross-checked the active enhancers thus identified against genes, identified by GWAS for the normal range human facial appearance. Among the identified active cis-enhancers, several belonged to the components of the PI3/AKT/mTORC1/autophagy pathway. To assess the functional role of this pathway, we manipulated it both genetically and pharmacologically in mice and zebrafish. These experiments revealed that mTORC1 signaling modulates craniofacial shaping at the stage of skeletal mesenchymal condensations, with subsequent fine-tuning during clonal intercalation. This ability of mTORC1 pathway to modulate facial shaping, along with its evolutionary conservation and ability to sense external stimuli, in particular dietary amino acids, indicate that the mTORC1 pathway may play a role in facial phenotypic plasticity. Indeed, the level of protein in the diet of pregnant female mice influenced the activity of mTORC1 in fetal craniofacial structures and altered the size of skeletogenic clones, thus exerting an impact on the local geometry and craniofacial shaping. Overall, our findings indicate that the mTORC1 signaling pathway is involved in the effect of environmental conditions on the shaping of craniofacial structures.

Indexed as

Signal TransductionZebrafishAnimalsDietFemaleHumansMechanistic Target of Rapamycin Complex 1MicePregnancyProteinsMechanistic Target of Rapamycin Complex 1Proteins

Identifiers

PMID38531868
PMCPMC10965948
OpenAlexW4393201566

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.